Haojie Lu

Haojie Lu

Auto-generated profile, based on publicly available information

Haojie Lu

Department of Dermatology Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University Hangzhou China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2021 in Pigment Cell & Melanoma Research
Verified
Journal Article
Closed access
PDF file
JXJinhui Xu
Jinhui Xu
HLHaojie Lu
Haojie Lu
HLHaixin Luo
Haixin Luo
YHYebei Hu
Yebei Hu
YCYi Chen
Yi Chen
XSXiuzu Song
Xiuzu Song

15 September 2021 in Australasian Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
HLHaojie Lu
Haojie Lu
JXJinhui Xu
Jinhui Xu
YHYebei Hu
Yebei Hu
HLHaixin Luo
Haixin Luo
YCYi Chen
Yi Chen
XSXiuzu Song
Xiuzu Song

5 June 2021 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
HLHaojie Lu
Haojie Lu
JXJinhui Xu
Jinhui Xu
BXBo Xie
Bo Xie
YHYebei Hu
Yebei Hu
HLHaixin Luo
Haixin Luo
XSXiuzu Song
Xiuzu Song
Network pharmacology is an emerging discipline that designs drugs based on systems biology theory and biological system network analysis. Here, we applied network pharmacology to analyze the multi-target mechanism of Cyclosporin A in the treatment of vitiligo First, we predicted the targets of Cyclosporin A. Second, we obtained the genes related to vitiligo from the database. Third, we constructed the PPI network of the mutual genes between Cyclosporin A and vitiligo and used gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) to analyze. Finally, we verified the prediction of potential targets through a docking study with Cyclosporin A. We found that there were 15 shared target genes between Cyclosporin A and vitiligo. We analyzed these 15 genes by Cytoscape and obtained a network diagram of 885 nodes. Through screening and molecular docking, PRKDC, CUL7, CUL1, HSPA8, HSPA4, and SIRT7 were the most likely multi-target mechanism of Cyclosporin A in the treatment of vitiligo. In our study, Cyclosporin A might not only affect the repair of DNA strands by targeting PRKDC, but also affected the innate and adaptive immune function of vitiligo patients by the targets of CUL1, CUL7, and HSP70. In addition, Cyclosporin A might promote the repigmentation of vitiligo by adjusting the expression of SIRT7.

1 October 2022 in Pigment Cell & Melanoma Research
Verified
Journal Article
Closed access
YHYebei Hu
Yebei Hu
YCYi Chen
Yi Chen
JXJinhui Xu
Jinhui Xu
HLHaixin Luo
Haixin Luo
HLHaojie Lu
Haojie Lu
XSXiuzu Song
Xiuzu Song